Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.
Saved in:
| Title: | Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12. |
|---|---|
| Authors: | Heitz, F.1 (AUTHOR) florian.heitz@gmx.net, Harter, P.1 (AUTHOR), Åvall-Lundqvist, E.1 (AUTHOR), Reuss, A.1 (AUTHOR), Pautier, P.1 (AUTHOR), Cormio, G.1 (AUTHOR), Colombo, N.1 (AUTHOR), Reinthaller, A.1 (AUTHOR), Vergote, I.1 (AUTHOR), Poveda, A.1 (AUTHOR), Ottevanger, P.B.1 (AUTHOR), Hanker, L.C.1 (AUTHOR), Leminen, A.1 (AUTHOR), Alexandre, J.1 (AUTHOR), Canzler, U.1 (AUTHOR), Sehouli, J.1 (AUTHOR), Herrstedt, J.1 (AUTHOR), Fiane, B.1 (AUTHOR), Merger, M.1 (AUTHOR), du Bois, A.1 (AUTHOR) |
| Source: | Gynecologic Oncology. Feb2019, Vol. 152 Issue 2, p235-242. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2018.11.008 |
